High expression of PD-L1 on tumor endothelial cells reduces CD8+ T cell infiltration and increases the aggregate of forkhead box P3 (FoxP3)+ Tregs in the tumor mass; anlotinib downregulates PD-L1 expression on tumor endothelial cells [30]. Here, FOXP3 is linked to neoplasm.